Friday 26th June 2020
New findings on lenabasum from RESOLVE-1 trial
Lenabasum is a synthetic drug that activates a certain receptor involved in the immune system and in the activity of fibroblasts, which drive fibrosis (scarring), and is particularly useful for diffuse cutaneous scleroderma.